The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials

被引:325
作者
Boellaard, Ronald [1 ]
Oyen, Wim J. G. [2 ]
Hoekstra, Corneline J. [1 ,3 ]
Hoekstra, Otto S.
Visser, Eric P. [2 ]
Willemsen, Antoon T. [4 ]
Arends, Bertjan [5 ]
Verzijlbergen, Fred J. [6 ]
Zijlstra, Josee [1 ]
Paans, Anne M. [4 ]
Comans, Emile F. I. [1 ]
Pruim, Jan [4 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Nucl Med & PET Res, NL-1081 HV Amsterdam, Netherlands
[2] Radbound Univ Nijmegen, Dept Nucl Med, Med Ctr, NL-6500 HB Nijmegen, Netherlands
[3] Jeroen Bosch Hosp, Dept Nucl Med, NL-5200 ME sHertogenbosch, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9700 RB Groningen, Netherlands
[5] Catharina Hosp, Dept Clin Phys, NL-5623 EJ Eindhoven, Netherlands
[6] St Antonius Hosp, Dept Nucl Med, NL-3435 CM Nieuwegein, Netherlands
关键词
Standardisation; FDG; PET; Multi-centre trials; QC; SUV; Quantification;
D O I
10.1007/s00259-008-0874-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction Several studies have shown the usefulness of positron emission tomography (PET) quantification using standardised uptake values (SUV) for diagnosis and staging, prognosis and response monitoring. Many factors affect SUV, such as patient preparation procedures, scan acquisition, image reconstruction and data analysis settings, and the variability in methodology across centres prohibits exchange of SUV data. Therefore, standardisation of 2-[F-18] fluoro-2-deoxy-D-glucose (FDG) PET whole body procedures is required in multi-centre trials. Methods A protocol for standardisation of quantitative FDG whole body PET studies in the Netherlands (NL) was defined. This protocol is based on standardisation of: (1) patient preparation; (2) matching of scan statistics by prescribing dosage as function of patient weight, scan time per bed position, percentage of bed overlap and image acquisition mode (2D or 3D); (3) matching of image resolution by prescribing reconstruction settings for each type of scanner; (4) matching of data analysis procedure by defining volume of interest methods and SUV calculations and; (5) finally, a multi-centre QC procedure is defined using a 20-cm diameter phantom for verification of scanner calibration and the NEMA NU 2 2001 Image Quality phantom for verification of activity concentration recoveries (i.e., verification of image resolution and reconstruction convergence). Discussion This paper describes a protocol for standardization of quantitative FDG whole body multi-centre PET studies. Conclusion The protocol was successfully implemented in the Netherlands and has been approved by the Netherlands Society of Nuclear Medicine.
引用
收藏
页码:2320 / 2333
页数:14
相关论文
共 49 条
  • [1] AHMADIAN A, 2008, EUR J NUCL MED MOL I, V5, P3542
  • [2] Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer
    An, Young-Sil
    Sheen, Seung S.
    Oh, Y. J.
    Hwang, Sung C.
    Yoon, Joon-Kee
    [J]. ANNALS OF NUCLEAR MEDICINE, 2007, 21 (10) : 585 - 592
  • [3] Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: Introduction and evaluation
    Antoch, G
    Kuehl, H
    Kanja, J
    Lauenstein, TC
    Schneemann, H
    Hauth, E
    Jentzen, W
    Beyer, T
    Goehde, SC
    Debatin, JF
    [J]. RADIOLOGY, 2004, 230 (03) : 879 - 885
  • [4] Antoch G, 2003, INVEST RADIOL, V38, P784, DOI 10.1097/01.rli.0000086495.96457.54
  • [5] Whole-body positron emission tomography-CT: Optimized CT using oral and IV contrast materials
    Antoch, G
    Freudenberg, LS
    Stattaus, J
    Jentzen, W
    Mueller, SP
    Debatin, JF
    Bockisch, A
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 179 (06) : 1555 - 1560
  • [6] Antoch G, 2002, J NUCL MED, V43, P1339
  • [7] Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose:: Use and limitations
    Avril, N
    Rosé, CA
    Schelling, M
    Dose, J
    Kuhn, W
    Bense, S
    Weber, W
    Ziegler, S
    Graeff, H
    Schwaiger, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3495 - 3502
  • [8] The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis
    Bastiaannet, E
    Groen, H
    Jager, PL
    Cobben, DCP
    van der Graaf, WTA
    Vaalburg, W
    Hoekstra, HJ
    [J]. CANCER TREATMENT REVIEWS, 2004, 30 (01) : 83 - 101
  • [9] PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients
    Berthelsen, AK
    Holm, S
    Loft, A
    Klausen, TL
    Andersen, F
    Hojgaard, L
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (10) : 1167 - 1175
  • [10] Beyer T, 2005, J NUCL MED, V46, P429